{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:52:24Z","timestamp":1780368744049,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10988-2","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T14:08:28Z","timestamp":1745417308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multicenter study in Turkiye of unsuppressed viremia in people living with human immunodeficiency virus: aegean experience"],"prefix":"10.1186","volume":"25","author":[{"given":"Ilkay","family":"Akbulut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Sedef","family":"Varol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veysel","family":"Akca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basak Gol","family":"Serin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Erogul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker","family":"Odemi\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seniha","family":"Senbayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabri","family":"Atalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"10988_CR1","unstructured":"Antiretroviral Drug Discovery and Development| NIH. National Institute of Allergy and Infectious Diseases. [cited 2021 Nov 6]. Available from: https:\/\/www.niaid.nih.gov\/diseases-conditions\/antiretroviral-drug-development"},{"issue":"7","key":"10988_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1377\/hlthaff.2018.05391","volume":"38","author":"SS Forsythe","year":"2019","unstructured":"Forsythe SS, McGreevey W, Whiteside A, et al. Twenty years of antiretroviral therapy for people living with HIV: global costs, health achievements, economic benefits. Health Aff. 2019;38(7):1163\u201372. https:\/\/doi.org\/10.1377\/hlthaff.2018.05391","journal-title":"Health Aff"},{"issue":"3","key":"10988_CR3","doi-asserted-by":"publisher","first-page":"e2540","DOI":"10.1002\/rmv.2540","volume":"34","author":"IH Mosha","year":"2024","unstructured":"Mosha IH, Nyondo GG, Munishi CG, et al. Prevalence and factors associated with viral non-suppression in people living with HIV receiving antiretroviral therapy in sub-Saharan Africa: a systematic review and meta-analysis. Rev Med Virol. 2024;34(3):e2540. https:\/\/doi.org\/10.1002\/rmv.2540","journal-title":"Rev Med Virol"},{"key":"10988_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijid.2023.01.025","volume":"129","author":"C Zhou","year":"2023","unstructured":"Zhou C, Wu Y, Zhang Y, Wang Y, et al. Factors associated with post-treatment control of viral load in HIV-infected patients: a systematic review and meta-analysis. Int J Infect Dis. 2023;129:216\u201327. https:\/\/doi.org\/10.1016\/j.ijid.2023.01.025","journal-title":"Int J Infect Dis"},{"key":"10988_CR5","unstructured":"World Health Organization\u20142016\u2014Consolidated guidelines. on the use of antiretrovir.pdf [cited 2021 Jun 22]. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/208825\/9789241549684_eng.pdf?sequence=1"},{"issue":"1","key":"10988_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41043-019-0194-0","volume":"38","author":"KH Misgina","year":"2019","unstructured":"Misgina KH, Weldu MG, Gebremariam TH, et al. Predictors of mortality among adult people living with HIV\/AIDS on antiretroviral therapy at Suhul hospital, Tigrai, Northern Ethiopia: a retrospective follow-up study. J Health Popul Nutr. 2019;38(1):37. https:\/\/doi.org\/10.1186\/s41043-019-0194-0","journal-title":"J Health Popul Nutr"},{"key":"10988_CR7","unstructured":"Statistics HIV-AIDS. Accessed February 10,. Contagious Diseases and Early Warning Department. Republic of Turkey Ministry of Health. Ankara, Turkey: Republic of Turkey Ministry of Health. https:\/\/hsgm.saglik.gov.tr\/depo\/birimler\/bulasici-hastaliklar-ve-erken-uyari-db\/Dokumanlar\/Istatistikler\/hiv-aids-2023 (2024)."},{"issue":"2","key":"10988_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.14744\/hnhj.2024.39145","volume":"64","author":"\u0130lkay","year":"2024","unstructured":"\u0130lkay, Akbulut, Sabri Atalay. Predictors of low-level viremia in people living with HIV with unsuppressed viremia, a retrospective follow-up study in Izmir. Haydarpasa Numune Med J. 2024;64(2):193\u20138. https:\/\/doi.org\/10.14744\/hnhj.2024.39145","journal-title":"Haydarpasa Numune Med J"},{"key":"10988_CR9","first-page":"112","volume":"20","author":"D Gokengin","year":"2019","unstructured":"Gokengin D, Cimen C, Cagatay A, et al. HIV cascade of care in Turkey: data from the HIV-TR cohort. HIV Med. 2019;20:112\u20133.","journal-title":"HIV Med"},{"key":"10988_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijid.2023.01.025","volume":"129","author":"C Zhou","year":"2023","unstructured":"Zhou C, Wu Y, Zhang Y, Wang Y, Wu H, Zhang T, Chen G, Huang X. Factors associated with post-treatment control of viral load in HIV-infected patients: a systematic review and meta-analysis. Int J Infect Dis. 2023;129:216\u201327. https:\/\/doi.org\/10.1016\/j.ijid.2023.01.025","journal-title":"Int J Infect Dis"},{"key":"10988_CR11","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Washington, DC: Department of Health and Human Services. https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv (2023, Accessed February 10, 2024)."},{"key":"10988_CR12","unstructured":"HIV\/AIDS Diagnosis, Monitoring, and Treatment Manual v3.0. http:\/\/www.aidsvecinselhastaliklar.com\/uploads\/files (Accessed February 14, 2024)."},{"key":"10988_CR13","unstructured":"World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: World Health Organization. 2007 [cited 2025 Mar 28]. Available from: https:\/\/www.who.int\/hiv\/pub\/guidelines\/HIVstaging150307.pdf"},{"issue":"6","key":"10988_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40266-023-01022-8","volume":"40","author":"D Lampe","year":"2023","unstructured":"Lampe D, Grosser J, Gensorowsky D, et al. The relationship of continuity of care, polypharmacy and medication appropriateness: A systematic review of observational studies. Drugs Aging. 2023;40(6):473\u201397. https:\/\/doi.org\/10.1007\/s40266-023-01022-8","journal-title":"Drugs Aging"},{"key":"10988_CR15","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S2352-3018(20)30234-4","volume":"8","author":"S Lewin","year":"2021","unstructured":"Lewin S, Attoye T, Bansbach C, et al. Multi-stakeholder consensus on a target product profile for an HIV cure. Lancet HIV. 2021;8:e42\u201350.","journal-title":"Lancet HIV"},{"key":"10988_CR16","unstructured":"National Institutes of Health. (2018). National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), version 5.0, November 2017. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm (Accessed February 10, 2024)."},{"issue":"7","key":"10988_CR17","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","volume":"15","author":"M Smit","year":"2015","unstructured":"Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10988_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/cid\/ciac762","volume":"76","author":"O Elvstam","year":"2023","unstructured":"Elvstam O, Malmborn K, El\u00e9n S, et al. Virologic failure following low-level viremia and viral blips during antiretroviral therapy: results from a European multicenter cohort. Clin Infect Dis. 2023;76(1):25\u201331. https:\/\/doi.org\/10.1093\/cid\/ciac762","journal-title":"Clin Infect Dis"},{"key":"10988_CR19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12879-020-05191-4","volume":"20","author":"H Y\u0131lmaz","year":"2020","unstructured":"Y\u0131lmaz H, Karaosmano\u011flu HK, T\u00fczer G, et al. Barriers to achieving virological suppression in a cohort of HIV patients in Istanbul. BMC Infect Dis. 2020;20:456.","journal-title":"BMC Infect Dis"},{"key":"10988_CR20","doi-asserted-by":"publisher","unstructured":"Akbulut I, Odemis I, Atalay S, et al. Comparison of clinician preference and HIV-ASSIST recommendations in antiretroviral therapy decision-making: a single center experience from Turkiye. Int J STD AIDS. 2024;9564624241229464. https:\/\/doi.org\/10.1177\/09564624241229464","DOI":"10.1177\/09564624241229464"},{"issue":"1","key":"10988_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2022.22246","volume":"329","author":"RT Gandhi","year":"2023","unstructured":"Gandhi RT, Bedimo R, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the international antiviral Society\u2013USA panel. JAMA. 2023;329(1):63\u201384. https:\/\/doi.org\/10.1001\/jama.2022.22246","journal-title":"JAMA"},{"key":"10988_CR22","doi-asserted-by":"publisher","unstructured":"Njuguna N, Mugo N, Anzala O, et al. An empiric tool to identify Kenyans living with HIV who will have unsuppressed viremia 18 months following treatment initiation to guide differentiated care models. PLoS ONE. 2022;17(7). https:\/\/doi.org\/10.1371\/journal.pone.0271520","DOI":"10.1371\/journal.pone.0271520"},{"issue":"4","key":"10988_CR23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/jac\/dkad056","volume":"78","author":"L Cuzin","year":"2023","unstructured":"Cuzin L, Flandre P, Allavena C, et al. Low-level viral loads and virological failure in the integrase strand transfer era. J Antimicrob Chemother. 2023;78(4):1111\u20136. https:\/\/doi.org\/10.1093\/jac\/dkad056","journal-title":"J Antimicrob Chemother"},{"key":"10988_CR24","doi-asserted-by":"publisher","unstructured":"Atuhaire P, Hanley S, Yende-Zuma N, et al. Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis. PLoS ONE. 2019;14(10). https:\/\/doi.org\/10.1371\/journal.pone.0219415","DOI":"10.1371\/journal.pone.0219415"},{"issue":"1","key":"10988_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12981-020-00328-6","volume":"18","author":"V Korten","year":"2021","unstructured":"Korten V, G\u00f6kengin D, Eren G, et al. Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR cohort, 2011\u20132017. AIDS Res Ther. 2021;18(1):4. https:\/\/doi.org\/10.1186\/s12981-020-00328-6","journal-title":"AIDS Res Ther"},{"issue":"2","key":"10988_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/ije\/dyr164","volume":"41","author":"C Lewden","year":"2012","unstructured":"Lewden C, Bouteloup V, De Wit S, et al. All-cause mortality in treated HIV-infected adults with CD4\u2009\u2265\u2009500\/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012;41(2):433\u201345.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10988_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.24875\/AIDSRev.21000011","volume":"23","author":"Z Wu","year":"2021","unstructured":"Wu Z, Yang C, Ma Y, et al. The prevalence of HIV-infected patients with virological suppression but a CD4\u2009+\u2009T-cell count of \u2264\u2009200 cells\/mm3 after highly active antiretroviral therapy initiation: a meta-analysis. AIDS Rev. 2021;23(2):75\u201385. https:\/\/doi.org\/10.24875\/AIDSRev.21000011","journal-title":"AIDS Rev"},{"key":"10988_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/HIV.S408565","volume":"15","author":"E Erjino","year":"2023","unstructured":"Erjino E, Abera E, Lemma Tirore L. Time to viral load suppression and its predictors among adult patients on antiretro viral therapy in Nigist Eleni Mohammed memorial comprehensive specialized hospital, Hossana, Southern Ethiopia. HIV AIDS (Auckl). 2023;15:157\u201371. https:\/\/doi.org\/10.2147\/HIV.S408565","journal-title":"HIV AIDS (Auckl)"},{"key":"10988_CR29","unstructured":"Kaplan JE, Benson C, Holmes KK et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;10 58(RR-4):1-207; Quiz CE1-4. PMID: 19357635."},{"issue":"1","key":"10988_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12981-018-0204-0","volume":"15","author":"PG Clay","year":"2018","unstructured":"Clay PG, Yuet WC, Moecklinghoff CH, et al. A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV. AIDS Res Therapy. 2018;15(1):17. https:\/\/doi.org\/10.1186\/s12981-018-0204-0","journal-title":"AIDS Res Therapy"},{"issue":"3","key":"10988_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/01.qai.0000186371.95301.52","volume":"41","author":"TR Glass","year":"2006","unstructured":"Glass TR, De Geest S, Weber R, et al. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV cohort study. J Acquir Immune Defic Syndr. 2006;41(3):385\u201392.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10988_CR32","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1093\/cid\/ciz590","volume":"70","author":"NE Winchester","year":"2020","unstructured":"Winchester NE, Maldarelli F, Mejia Y, et al. Eight-day inpatient directly observed therapy for antiretroviral therapy (ART) failure: a tool for preventing unnecessary ART changes and optimizing adherence support. Clin Infect Dis. 2020;70(6):1222\u20135. https:\/\/doi.org\/10.1093\/cid\/ciz590","journal-title":"Clin Infect Dis"},{"key":"10988_CR33","doi-asserted-by":"publisher","first-page":"8961372","DOI":"10.1155\/2023\/8961372","volume":"2023","author":"MM Nzivo","year":"2023","unstructured":"Nzivo MM, Waruhiu CN, Kang\u2019ethe JM, Wamalwa DC, Nduati R, Otwoma NJ. HIV virologic failure among patients with persistent low-level viremia in Nairobi, Kenya: it is time to review the >\u20091000 virologic failure threshold. Biomed Res Int. 2023;2023:8961372. https:\/\/doi.org\/10.1155\/2023\/8961372","journal-title":"Biomed Res Int"},{"key":"10988_CR34","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.2147\/IDR.S332924","volume":"14","author":"Q Li","year":"2021","unstructured":"Li Q, Chen M, Zhao H, Yu F, Yan L, Xiao J, et al. Persistent low-level viremia is an independent risk factor for virologic failure: a retrospective cohort study in China. Infect Drug Resist. 2021;14:3259\u201366. https:\/\/doi.org\/10.2147\/IDR.S332924","journal-title":"Infect Drug Resist"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10988-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10988-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10988-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T14:08:33Z","timestamp":1745417313000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10988-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10988"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10988-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research received ethical approval from the ethics committee of Tepecik Training Hospital (approval date\/number: 04.06.2024\/05\u201302) and the hospital administration overseeing the recruitment of participants. This study was conducted in accordance with the principles of the Declaration of Helsinki. Informed Consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"587"}}